5'-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome

E-ISSN： 2212-3873|11|3|206-216

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.11, Iss.3, 2011-01, pp. : 206-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 908-920

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of the dsRNA-Activated Protein Kinase PKR in Mitochondrial Dysfunction and Inflammatory Stress in Metabolic Syndrome

Current Pharmaceutical Design, Vol. 22, Iss. 18, 2016-05 ,pp. : 2697-2703

Bentham Science Publishers

Access to resources Recommend Favorite

Differential involvement of 3′, 5′-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal

By Almela Pilar Cerezo Manuela González-Cuello A. Milanés M. Laorden M.

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 4, 2007-01 ,pp. : 293-303

Springer Publishing Company

Access to resources Recommend Favorite

AMP activated protein kinase: a next generation target for total metabolic control

By Misra Parimal

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 91-100

Informa Healthcare

Access to resources Recommend Favorite

Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A 3 receptor in transfected CHO cells

By Graham S. Combes P. Crumiere M. Klotz K.-N. Dickenson J.M.

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 19-26

Elsevier

Access to resources Recommend Favorite